医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Korean Cosmetic Brand PETITCOMO Launches Bling Bling Light Up Masks for Summer Skin Treatment

2019年07月05日 PM01:44
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

PETITCOMO, a Korean cosmetic brand, has launched two types of Bling Bling Light Up Masks which contain EWG green grade natural ingredients.

These new sheet masks, Ampoule Mask Black Edition and Aqua Mask White Edition, infuse elasticity and vividness into skins affected by hot weather. They are also effective for improving skin tone.

Ampoule Mask Black Edition contains a variety of ingredients such as propolis extract, royal jelly extract, lavender oil, and orange peel oil which are great for skin nourishment and elasticity improvement. Meanwhile, Aqua Mask White Edition soothes heat-affected skins by infusing a rich and comfort watery feeling with its ingredients including Lactobacillus fermentum, purslane extract, and chamomile oil.

The masks’ triple-layer-embossing Bella soft sheets are made of bamboo which enables high adherence and low irritation to the skin.

“These mask products are made by the renowned cosmetic brand, featuring high-quality natural ingredients and advanced technology. Users will recognize its moisturizing effects immediately after using this product. The products also make their makeup more effective,” said an official from AMAX HOLDINGS, a manufacturer of PETITCOMO. “We are preparing to launch a variety of new lineup consistently.”

AMAX HOLDINGS has gained much attention with its stage-by-stage skincare program ACOLAB Miracle System Total Solution, which allows consumers to manage their skin themselves at home like an expert from a professional aesthetic shop at low cost.

ACOLAB Miracle System Total Solution is composed of several stages from peeling gel, MTS to soothing recovery cream care.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190704005356/en/

CONTACT

For AMAX HOLDINGS

ADExpo Korea Co., Ltd.

Jinju Lee, +82-2-6010-1102

adexpo@adexpo.co.kr

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Daiichi Sankyo Announces Clinical Research Collaboration to Evaluate DS-1062 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Non-Small Cell Lung Cancer
  • ENHERTU® Significantly Improved Tumor Response Rate and Overall Survival in HER2 Positive Metastatic Gastric Cancer in Pivotal Phase 2 DESTINY-Gastric01 Trial
  • ENHERTU® Demonstrated Meaningful Clinical Activity in Patients with HER2 Mutant Non-Small Cell Lung Cancer in Interim Analysis of Phase 2 DESTINY-Lung01 Trial
  • ENHERTU® Achieved a Tumor Response Rate of 45.3% in Patients with HER2 Positive Metastatic Colorectal Cancer in Phase 2 DESTINY-CRC01 Trial
  • Takeda to Present Data from the ICLUSIG® (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML